Drugdevelopment
News, views and contacts from the global Drugdevelopment industry
26 February 2017
DAILY UPDATE
Industry News

M&As this week: Zhejiang Conba Pharma, CHA Healthcare
Conba Group’s subsidiary Zhejiang Conba Pharmaceutical has completed the sale of 57.3% stake in a pharmaceutical company.

GSK and Innoviva report positive results from clinical study of relvar ellipta for asthma
UK-based pharmaceutical firm GlaxoSmithKline (GSK) and US-based healthcare firm Innoviva have reported positive headline results from a non-inferiority lung function study of relvar ellipta in patients with well-controlled asthma.

Deals this week: Modus Therapeutics Holding, Mercachem, Ally Bridge Group
Swedish biopharmaceutical company Modus Therapeutics Holding has raised Skr32m ($3.6m) from its existing investors including KDev Investments, Ostersjostiftelsen and Praktikerinvest.

NIH begins Phase I trial of DS-Cav1 to treat respiratory syncytial virus
The National Institutes of Health (NIH) in the US has begun the Phase I clinical trial (VRC 317) of an investigational vaccine DS-Cav1 for the treatment of respiratory syncytial virus (RSV).

Press Releases

Malvern to Host Webinar on Characterisation and Optimisation of Particle Size and Shape of Metal Powders
Efficiency of the production process of powder bed additives is reliant on packing density and flow behaviour of metal powders involved.

Malvern to Unveil New Protein Stability Analysis Device
Malvern has announced it will be unveiling its new protein stability characterisation product for regulated environments MicroCal PEAQ-DSC in an upcoming webinar.

Understanding Particle Size Analysis Webinar
Malvern has announced that it will be presenting a webinar on the basic principles of particle size analysis.

SYSTAG Accelerates OEM Product Development and Software Services
Based in Switzerland, SYSTAG System Technik is accelerating its original equipment manufacturer (OEM) product development, software engineering, and software services, in addition to its own products in automated laboratory reactors and thermal process safety.

Gaining an Understanding of Pharmacokinetic Protocols
Engaged in pharmaceutical consulting, the scientists and regulatory professionals at PDG® are tasked with design of pharmacokinetic (PK) protocols for a wide variety of applications.

White Papers

ePAT Automated Lab Reactor Optimised for 24/7 Data Capture
Systag Systems presents ePAT, a cost-effective device for automation in the laboratory....

How Investing in Malvern Instruments Helped KBI Biopharma Find a Clear Commercial Advantage
Differing sample matrices and presentation can create various challenges, not least for KBI's technology platforms, which often require specialised methods and application experts in order...

Optimising Development Resources for Efficient Product Development
Development departments suffer from a shortage of resources and are often overburdened with administration...

GPC/SEC Analysis of Polymer Solutions Used in Inkjet Printing
Inkjet printing of polymer solutions is an area of interest for depositing precise, high-throughput patterns of functional polymer. The applications of the polymer patterns include OLEDs,...

Gold Nanoparticle Applications and Characterization by Nanoparticle Tracking Analysis
Gold nanoparticles are one of the most popular and extensively researched type of nanoparticle. A Google Scholar search of the term 'gold nanoparticles' results in more than 500,000...

Follow Us:   Facebook Facebook    Twitter Twitter   
Click here to unsubscribe from the newsletter | Privacy Policy
You are receiving this email because you are either a valued subscriber to Drug Development Technology or have signed up via a partner web site. Your email address has not been, and will not be, given to third parties.

www.drugdevelopment-technology.com is a product of Kable. Copyright 2017 Kable, a trading division of Kable Intelligence Limited.